1Odawa. R. Keloids as a serious disease such as malignancy. Plast Reconstr Surg, 2008,122:993-994.
2Colwell AS, Yun R, Krummel TM, et al. Keratinocytes modulate fetal and postnatal fibroblast transforming growth factor-beta and Smad expression in co-culture. Plast Reconstr Surg, 2007,119 : 1440-1445.
3Dang CM, Beanes SR, Soo C, et al. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg,2003,111 : 1969-1979.
4Mukhopadhyay A, Tan EK, Khoo YT, et al. Conditioned medium from keloid keratinocyte/keloid fibroblast cocuhure induces contraction of fibroblast-populated collagen lattices. Br J Dermatol,2005,152:639-645.
5Meier K, Nanney LB. Emerging new drugs for scar reduction. Expert Opin Emerg Drugs ,2006,11:3947.
7Mukhopadhyay A, Wong MY, Chan SY, et al. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis. J Trauma,2010,68:999-1008.
8Shimizu T, Kanai K, Kyo Y, et al. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro. J Pharm Pharmaco1,2006,58:91-99.
